Searched for
CIPLA BUYOUT
Sun Pharma closes in on Organon buy, gets set for $12 billion binding bidSun Pharmaceutical Industries is nearing a $12 billion acquisition of Organon & Co, marking its most significant overseas expansion. Follow...- Torrent talks for $7 billion Cipla buyout trip on valuationTorrent Pharma's attempt to acquire the stake of the Hamied family in Cipla has hit a roadblock due to differences in valuation. Talks betw...
- Cipla stake sale plan faces hurdle as promoters differ on valuation: ReportCipla's potential stake sale faces a challenge due to disagreements among its promoters regarding the company's valuation. This dispute amo...
- Torrent Pharma looks to tie up with CVC Capital to fund Cipla purchaseTorrent Pharmaceuticals is in advanced talks with CVC Capital Partners to raise at least $1.2-1.5 billion for its proposed acquisition of r...
- Torrent Pharma says it has no disclosure to make now on potential Cipla stake buy deal reportsTorrent Pharma has stated that it does not have any information to disclose under listing regulations, in response to reports about the com...
- Torrent in top gear to close out Cipla buyout, in talks with PEs, banks for fundsRival contenders Blackstone, Baring Asia hit pause mode as Cipla valuations soar. Torrent taps PE funds like Warburg Pincus, CVC among othe...
- Blackstone sets its sights on buying out Hamieds from CiplaNon-binding bid likely next week for 33.4% stake, will trigger open offer for 26% more. At current mkt value deal size could be over $6 bn ...
- Medley-Cipla deal talks called off over valuation issuesThis is the second pharma merger and acquisition (M&A) transaction that has been called off or postponed recently due to market volatility ...
- Even after poor results, Cipla stock may just be the right pick nowThe US business is 20% of total revenues. As the proportion of this high-margin business grows, it will help Cipla improve profitability.
- Cipla ends 3% down even as company only Indian firm in race for Kremers UrbanIndia's third largest drug maker posted a net profit of Rs 294.58 crore for the corresponding period of the previous fiscal year.
- Cipla plans to acquire US-based pharma cos; stock inches upSources indicated that Cipla is in talks to acquire companies with large manufacturing units in generics, respiratory and oncology spaces.
- Cipla bags Rs 1,100 crore order from South African governmentCipla Medpro, the SA subsidiary of the Indian firm, has bagged the order as part of the South African government's 2015-17 National ARV ten...
- Cipla signs pact with Teva Pharmaceuticals for selling drugs in South AfricaThe collaboration will focus on oncology, central nervous system, women's health, cardiovascular, ophthalmology and other speciality produc...
- Cipla inks pact to acquire 51% stake in Yemeni companyAs part of its global expansion, Cipla had completed the buyout of South African pharma firm Cipla Medpro for Rs 2,707 crore last year.
- Cipla unit gets 345 million rand contract from South AfricaUnder the contract, which will run from July 2014 to April 2017, the company will supply drugs including Beclate 100, Becalate 200 and Asth...
- Cipla acquires 60% stake in Sri Lankan firm; stock up nearly 3%As part of its global expansion, Cipla has been active in acquisitions. Last year, it completed the buyout of South African pharma firm, sa...
- Cipla buys 60% stake in Sri Lankan co for $14 million"The consideration payable for the transaction is $14 million," the filing said, adding that the proposed acquisition was subject to regula...
- Cipla completes buyout of Cipla Medpro for Rs 2,707 croreCipla on Tuesday said it has completed the buyout process of South African pharma firm Cipla Medpro for an aggregate consideration of Rs 2,...
- Cipla Medpro shareholder wants Cipla India to hike offer: ReportCipla Medpro is a South African affiliate of Cipla. The companies enjoy a long-standing business relationship spanning two decades.
- Cipla puts Medpro buyout on hold over valuation issuesCipla decides to put on hold its $220-million acquisition plan of the third-largest South African drugmaker Cipla Medpro due to valuation i...
Load More
